Explore

ICAIR 2019

12th International conference on Allergy, Immunology & Rheumatology 2019

Paris, France
21 - 23 February 2019
The conference ended on 23 February 2019

Important Dates

Abstract Submission Deadline
15th September 2018
Early Bird Deadline
15th September 2018
Abstract Acceptance Notification
15th October 2018
Final Abstract / Full Paper Deadline
15th November 2018

About ICAIR 2019

Here we propose a gregarious invite to all the Directors, Deans, Heads, Scientists, Professors, Speakers, Research professionals and expertise in the field of allergy, immunology & rheumatology and sponsors from all over the world to this prestigious event named with its series as “12th International conference on Allergy, Immunology & Rheumatology” that is going to be held on February 21-23, 2019 in the City of Lights Paris, France. The live format of this educational activity will be accredited with CPD Credits.

Topics

Immunohistochemistry, Food allergies and intolerances, Immunotherapy, Cancer and the immune system, Immunomodulation therapy, Allergy, Autoimmunes disease in women, Immunopathology, Neonatal rheumatology, Immunity, Immunization, Immunology chemistry, Immuno-oncology, Immune deficiencies, Cellular immunotherapy, Clinical immunology, Rheumatology and related diseases, Pediatric immunology, Neonatal otorhinolaryngology & rheumatology, Ocular microbiology and immunology, Allergy and immunology, Immunology of infections, Allergies in pediatrics, Immunology

Call for Papers

Allergy Types of Allergy Causative agents of Allergy Diagnostic tests for Allergy Prevention & Management on Allergy Immunology Cellular Immunology Medical Immunology Immuno-oncology Immunedisorders Immunotherapy Rheumatology Arthritis Rheumatic diseases Paediatric Allergy, Immunology and Rheumatology Advancements in Allergy, Immunology and Rheumatology Case studies of Allergy, Immunology and Rheumatology

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.